| How probiotics affect the microbiota G Wieërs, L Belkhir, R Enaud, S Leclercq, JM Philippart de Foy, ... Frontiers in cellular and infection microbiology 9, 454, 2020 | 455 | 2020 |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled … F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ... The Lancet infectious diseases 22 (2), 209-221, 2022 | 373 | 2022 |
| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 12 (1), 2349, 2021 | 357 | 2021 |
| SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule A Werion, L Belkhir, M Perrot, G Schmit, S Aydin, Z Chen, A Penaloza, ... Kidney international 98 (5), 1296-1307, 2020 | 277 | 2020 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 270 | 2022 |
| Immune-mediated neurological syndromes in SARS-CoV-2-infected patients A Guilmot, S Maldonado Slootjes, A Sellimi, M Bronchain, B Hanseeuw, ... Journal of neurology 268, 751-757, 2021 | 203 | 2021 |
| Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants L Catteau, N Dauby, M Montourcy, E Bottieau, J Hautekiet, ... International journal of antimicrobial agents 56 (4), 106144, 2020 | 140 | 2020 |
| Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae A Froidure, A Mahsouli, G Liistro, J De Greef, L Belkhir, L Gérard, ... Respiratory medicine 181, 106383, 2021 | 113 | 2021 |
| Clinical impact of MALDI-TOF MS identification and rapid susceptibility testing on adequate antimicrobial treatment in sepsis with positive blood cultures A Verroken, L Defourny, O Le Polain De Waroux, L Belkhir, PF Laterre, ... PLoS One 11 (5), e0156299, 2016 | 94 | 2016 |
| Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial GR Thompson, A Soriano, OA Cornely, BJ Kullberg, M Kollef, J Vazquez, ... The Lancet 401 (10370), 49-59, 2023 | 80 | 2023 |
| Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis E de Azambuja, M Brandão, H Wildiers, A Laenen, S Aspeslagh, ... ESMO open 5 (5), e000947, 2020 | 75 | 2020 |
| Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients V Montiel, I Lobysheva, L Gerard, M Vermeersch, D Perez-Morga, ... EBioMedicine 77, 2022 | 74 | 2022 |
| Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with … JC Yombi, D Maiter, L Belkhir, A Nzeusseu, B Vandercam Clinical rheumatology 27, 79-82, 2008 | 66 | 2008 |
| Follow-up of functional exercise capacity in patients with COVID-19: It is improved by telerehabilitation I Martin, F Braem, L Baudet, W Poncin, S Fizaine, F Aboubakar, ... Respiratory medicine 183, 106438, 2021 | 60 | 2021 |
| COVID-19 infection in kidney transplant recipients: a single-center case series of 22 cases from Belgium A Devresse, L Belkhir, B Vo, B Ghaye, A Scohy, B Kabamba, E Goffin, ... Kidney medicine 2 (4), 459-466, 2020 | 53 | 2020 |
| Streptococcus gordonii septic arthritis : two cases and review of literature JC Yombi, L Belkhir, S Jonckheere, D Wilmes, O Cornu, B Vandercam, ... BMC Infectious Diseases 12, 1-5, 2012 | 52 | 2012 |
| Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID‐19 patients R Soleimani, M Khourssaji, D Gruson, H Rodriguez‐Villalobos, ... Journal of medical virology 93 (3), 1465-1477, 2021 | 51 | 2021 |
| A biological profile for diagnosis and outcome of COVID-19 patients M Khourssaji, V Chapelle, A Evenepoel, L Belkhir, JC Yombi, ... Clinical Chemistry and Laboratory Medicine (CCLM) 58 (12), 2141-2150, 2020 | 42 | 2020 |
| Tigecycline-induced acute pancreatitis: about two cases and review of the literature JC Marot, S Jonckheere, H Munyentwali, L Belkhir, B Vandercam, ... Acta Clinica Belgica 67 (3), 229-232, 2012 | 40 | 2012 |
| Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: a retrospective study from an academic center in Belgium L Orioli, T Servais, L Belkhir, PF Laterre, JP Thissen, B Vandeleene, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (1), 149-157, 2021 | 35 | 2021 |